Page last updated: 2024-11-02

phenobarbital and Psoriasis

phenobarbital has been researched along with Psoriasis in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koukoulis, A1
Sopeña, B1
Muñoz, D1
de la Fuente, J1

Other Studies

1 other study available for phenobarbital and Psoriasis

ArticleYear
[The Stevens-Johnson syndrome induced by phenobarbital in a patient with Becker's disease].
    Anales de medicina interna (Madrid, Spain : 1984), 1994, Volume: 11, Issue:6

    Topics: Adolescent; Genetic Linkage; Humans; Male; Muscular Dystrophies; Phenobarbital; Psoriasis; Seizures;

1994